Medtronic's Vice President and General Manager of Cardiac Pacing Therapies, Robert Kowal, announced the 10 millionth set on social media.Leadless Pacemaker---The Micra series was completed at the Switzerland plant, marking a wonderful celebration of thirty years of innovation and operational excellence.
Micra SeriesThe leadless pacemaker is the smallest leadless pacemaker currently available on the market and also the most commercially successful leadless pacemaker. Since its introduction in 2013, it has been renowned for its reliable performance and excellent clinical outcomes (Complication rate decreased by 60% compared to traditional pacemakers.Becoming the preferred choice for patients with bradycardia. As of 2024, the Micra series of leadless pacemakers have completed over 200,000 surgeries.Currently, the NMPA has approved Medtronic's most advanced Micra series leadless pacemakers (Micra AV2 & Micra VR2）。New GenerationMicra pacemaker reduced to ChinaPatients with bradycardiaProvide a new treatment option that is less invasive and safer.Micra AV2 & Micra VR2
Micra AV2 & Micra VR2It is an upgrade of Medtronic's first-generation leadless pacemaker, with its appearance and most of the design continuing from the first generation. Therefore, its surgical method is also similar to the first generation.Leadless PacingLike a device, it also has the first generationLeadless PacingAll the advantages of the device.
Micra AV2 & Micra VR2Same as the previous generation, both areThe world's smallest pacemaker on the market, with a volume only the size of a vitamin capsule. It is 93% smaller than traditional pacemakers and weighs only about 1.75 grams.
Advantages of Micra AV2 & Micra VR2 over the first generationThrough innovation, the battery life of Micra AV2 & Micra VR2 has increased by 40% compared to the first generation, resulting in a median battery life of 16-17 years. This means that over 80% of patients will only need one Micra device for their lifetime.- Automatic AV Synchronization
Micra AV2 can automatically customize AV synchronization settings for each patient, reducing the need for manual programming by more than 50% compared to Micra AV1. The smarter algorithm also enhances automatic AV synchronization, responds faster when the heart rate is between 80–100 bpm, and now has a tracking rate upper limit of 135 bpm.The updated delivery system now features a rounded catheter tip with a larger surface area to reduce tip pressure during device implantation.
Micra is the only leadless pacemaker with remote monitoring capabilities, which enables doctors toInLineCheck the patient's cardiac device without the need for the patient to visit the hospital. Other benefits of remote monitoring for patients may include reduced hospitalizations and increased peace of mind.
Micra AV2 & Micra VR2 Specific Parameters
Headquartered in Dublin, Ireland, Medtronic is one of the largest medical technology, services, and solutions companies in the world — alleviating pain, restoring health, and extending life for millions of people globally. With over 90,000 employees worldwide, Medtronic serves doctors, hospitals, and patients in more than 150 countries. The company focuses on collaborating with stakeholders around the world to advance healthcare.
